Dual specificity phosphatase 6 suppresses the growth and metastasis of prostate cancer cells

December 2014
Molecular Medicine Reports;2014, Vol. 10 Issue 6, p3052
Academic Journal
Dual specificity phosphatase 6 (DUSP6) is expressed at low levels in numerous types of human cancer. The loss of DUSP6 plays a pivotal role in tumor progression; however, the role of DUSP6 in prostate cancer remains unclear. In this study, in vitro invasion assays and in vivo metastasis experiments were used to investigate the effects of DUSP6 on prostate cancer cell invasion and metastasis. Furthermore, in vitro growth and soft agar assays and in vivo growth experiments were performed to determine the function of DUSP6 in cell proliferation. The results showed that the overexpression of DUSP6 suppressed the invasion and growth of DU-145 human prostate cancer cells, whereas knockdown of DUSP6 promoted the invasion and proliferation of LNCap human prostate adenocarcinoma cells. Further experiments demonstrated that the overexpression of DUSP6 inhibited the proliferation and liver metastasis of DU-145 cells in mice. In addition, DUSP6 downregulated the expression of matrix metallopeptidase 3 and interleukin 8 in prostate cancer cells. Taken together, these findings indicate that DUSP6 may act as a negative mediator in the regulation of prostate cancer cell growth and metastasis.


Related Articles

  • Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2. Liu, Kangdong; Park, Chanmi; Li, Shengqing; Lee, Ki Won; Liu, Haidan; He, Long; Soung, Nak Kyun; Ahn, Jong Seog; Bode, Ann M.; Dong, Ziming; Kim, Bo Yeon; Dong, Zigang // Carcinogenesis;Jul2012, Vol. 33 Issue 7, p1406 

    Phosphatidylinositol 3-kinase (PI3-K) amplification and phosphatase and tensin homolog (PTEN) deletion-caused Akt activation contribute to the development of prostate cancer. Mammalian target of rapamycin complex 2 (mTORC2) is a kinase complex comprised of mTOR, Rictor, mSin1, mLST8/GβL and...

  • Role of the EpCAM (CD326) in prostate cancer metastasis and progression. Ni, Jie; Cozzi, Paul; Duan, Wei; Shigdar, Sarah; Graham, Peter; John, Kearsley; Li, Yong // Cancer & Metastasis Reviews;Dec2012, Vol. 31 Issue 3/4, p779 

    Despite significant advances in surgery, radiotherapy and chemotherapy to treat prostate cancer (CaP), many patients die of secondary disease (metastases). Current therapeutic approaches are limited, and there is no cure for metastatic castration-resistant prostate cancer (CRPC). Epithelial cell...

  • Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer. Inoue, Takahiro; Ogawa, Osamu // Prostate Cancer (20903111);2011, p1 

    Almost all patients who succumb to prostate cancer die of metastatic castration-resistant disease. Although docetaxel is the standard treatment for this disease and is associated with modest prolongation of survival, there is an urgent need for novel treatments for castration-resistant prostate...

  • Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer. Sluis, Tim; Bijnsdorp, Irene; Jacobs, John; Meuleman, Eric; Rozendaal, Lawrence; Geldof, Albert; Moorselaar, R.; Vis, André // World Journal of Urology;Apr2013, Vol. 31 Issue 2, p261 

    Purpose: Prostate cells are dependent on androgens for growth and proliferation. Androgen deprivation therapy is the recommended treatment for advanced/metastatic prostate cancer. Under this therapy, prostate cancer will inevitably progress to castration resistant prostate cancer (CRPC). Despite...

  • Cardiolipin composition correlates with prostate cancer cell proliferation. Sapandowski, Anja; Stope, Matthias; Evert, Katja; Evert, Matthias; Zimmermann, Uwe; Peter, Daniela; Päge, Ilona; Burchardt, Martin; Schild, Lorenz // Molecular & Cellular Biochemistry;Dec2015, Vol. 410 Issue 1/2, p175 

    Prostate cancer (PC) is the second most diagnosed cancer in men. It has been recognized that diet can play a crucial role in PC genesis and progression. In this context, free fatty acids are considered as modulators of cell proliferation. Recently, a relationship between the composition of the...

  • Prognostic Significance of Neuroendocrine Differentiation in Prostate Adenocarcinoma. Sagnak, Levent; Topaloglu, Hikmet; Ozok, Ugur; Ersoy, Hamit // European Journal of Clinical & Medical Oncology;2012, Vol. 4 Issue 3, p7 

    Much progress has been made towards an understanding of the development and progression of prostate cancer (PC), and the factors which drive the development of androgen independence. Neuroendocrine (NE) cells may provide an intriguing link between NE cell differentiation (NED) and tumor...

  • Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters. Melling, Nathaniel; Thomsen, Erik; Tsourlakis, Maria Christina; Kluth, Martina; Hube-Magg, Claudia; Minner, Sarah; Koop, Christina; Graefen, Markus; Heinzer, Hans; Wittmer, Corinna; Sauter, Guido; Wilczak, Waldemar; Huland, Hartwig; Simon, Ronald; Schlomm, Thorsten; Steurer, Stefan; Krech, Till // Carcinogenesis;Nov2015, Vol. 36 Issue 11, p1333 

    Enhancer of zeste homolog 2 (EZH2) plays an important role in tumor development and progression by interacting with histone and nonhistone proteins. In the current study, we analyzed prevalence and prognostic impact of EZH2 in prostate cancer. EZH2 expression was analyzed by immunohistochemistry...

  • The expression and functional role of FOX transcription factor FOXJ1 in prostate cancer. Qi An; Dezhong Liu; Lian Zou // International Journal of Clinical & Experimental Medicine;2017, Vol. 10 Issue 1, p285 

    As one common malignant tumor in male reproductive-urinary system, the incidence of prostate cancer is increasing rapidly. Recent study revealed the participation of FOX transcription factor family in tumor occurrence and progression. FOXJ1, one member of FOX family, plays an important role in...

  • Neurologic Complications of Prostate Cancer. Benjamin, Ramsis // American Family Physician;5/1/2002, Vol. 65 Issue 9, p1834 

    Provides information on neurologic complications of prostate cancer. Details on the anatomy of the disease; Symptoms and diagnosis of spinal metastasis; Treatment of brain metastasis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics